OBJECTIVES: This study was designed to assess the prevalence and persistence of symptoms of depression and anxiety during the first 12 months following acute myocardial infarction (MI). DESIGN AND METHODS: In a prospective study, 288 MI patients were assessed for symptoms of depression and anxiety using the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI) in hospital, 2-15 days following MI, and 4 and 12 months subsequently. RESULTS: During hospitalization, 89 (30.9%) and 75 (26.1%) patients registered elevated BDI scores (>/=10) and state anxiety scores (>/=40), respectively. The 4 and 12 month prevalence rates were 37.7% and 37.2% for depressive symptoms, and 41.8% and 40.0% for anxious symptoms, respectively. Depression and anxiety were highly co-morbid, with 51% of patients experiencing significant levels of depressive and anxious symptoms at baseline. More than half the patients with complete BDI and state anxiety data experienced either elevated symptoms of anxiety or depression throughout the first year following MI. CONCLUSIONS: Symptoms of depression and anxiety are prevalent, persistent problems during the first year following MI. This study highlights the importance of routine psychological assessment for MI patients both in hospital and after discharge.
OBJECTIVES: This study was designed to assess the prevalence and persistence of symptoms of depression and anxiety during the first 12 months following acute myocardial infarction (MI). DESIGN AND METHODS: In a prospective study, 288 MI patients were assessed for symptoms of depression and anxiety using the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI) in hospital, 2-15 days following MI, and 4 and 12 months subsequently. RESULTS: During hospitalization, 89 (30.9%) and 75 (26.1%) patients registered elevated BDI scores (>/=10) and state anxiety scores (>/=40), respectively. The 4 and 12 month prevalence rates were 37.7% and 37.2% for depressive symptoms, and 41.8% and 40.0% for anxious symptoms, respectively. Depression and anxiety were highly co-morbid, with 51% of patients experiencing significant levels of depressive and anxious symptoms at baseline. More than half the patients with complete BDI and state anxiety data experienced either elevated symptoms of anxiety or depression throughout the first year following MI. CONCLUSIONS: Symptoms of depression and anxiety are prevalent, persistent problems during the first year following MI. This study highlights the importance of routine psychological assessment for MI patients both in hospital and after discharge.
Authors: Benjamin L Willis; David Leonard; Carolyn E Barlow; Scott B Martin; Laura F DeFina; Madhukar H Trivedi Journal: JAMA Psychiatry Date: 2018-09-01 Impact factor: 21.596
Authors: Ian M Kronish; Nina Rieckmann; Ethan A Halm; Daichi Shimbo; David Vorchheimer; Donald C Haas; Karina W Davidson Journal: J Gen Intern Med Date: 2006-08-09 Impact factor: 5.128
Authors: Elizabeth P Knight; Kimberly Shea; Anne G Rosenfeld; Sarah Schmiege; Chiu-Hsieh Hsu; Holli A DeVon Journal: Nurs Res Date: 2016 Jul-Aug Impact factor: 2.381
Authors: Terese Sara Hoej Joergensen; Solvej Maartensson; Else Helene Ibfelt; Martin Balslev Joergensen; Ida Kim Wium-Andersen; Marie Kim Wium-Andersen; Eva Prescott; Per Kragh Andersen; Merete Osler Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2016-08-19 Impact factor: 4.328